...) following total thyroidectomy for differentiated thyroid cancer (DTC) changed. Major revisions of the American Thyroid Association (ATA) Guidelines in 2015 resulted in significant differences in treatment recommendations in comparison to the European Association of Nuclear Medicine (EANM) 2008 guidelines...

...Nerina Denaro; Adele Latina; Flora Cesario; Fabio Bramardi; Lauro Corrado; Giorgio Borretta; Marco Carlo Merlano Lenvatinib (LEN) is a multikinase inhibitor with antiangiogenic properties recently approved in radioactive iodine-refractory differentiated thyroid cancer, hepatocellular carcinoma...

... <6 cost CAD 4,694 per patient. Tuttle et al. [ 22 ] suggested adapting treatment to the risk of mortality and risk of recurrence when considering adjuvant RAI; they recommended ablative RAI in patients who are at intermediate to high risk of dying from thyroid cancer or at high risk of recurrence...

...Sarah E. Mayson; Don C. Yoo; Geetha Gopalakrishnan The incidence of differentiated thyroid cancer has increased worldwide over the last three decades, but thyroid cancer-related mortality remains stable. Until recently, the standard treatment for most thyroid cancers has been near-total...

...Robert G. Bennett; Shannon E. Wakeley; Frederick G. Hamel; Robin R. High; Christopher Korch; Whitney S. Goldner The association between vitamin D and thyroid cancer is unclear. It is unknown if CYP27A1 or CYP2R1 are present in normal thyroid or cancer cells and there is limited information...

... and in 1 out of 27 patients with thyroid cancer. We failed to find more than one copy of ERBB-2 in 34 patients with lung cancers, 6 with sarcomas and 3 with melanomas. There was tendency toward correlation between ERBB-2 amplification and lymph node involvement in patients with breast carcinoma. Thus...

... in 153 patients with highly differentiated thyroid cancer. In 29 of 32 metastatic patients a pathologically elevated (70–100 ng/ml) thyroglobulin level was observed. This proves the 91% specificity of the method in verified metastatic tumours. Compared to the total body scintigraphy 3 false-negative...

...A.A.R. Gossage; F.E. Neal; C.M.D. Ross; C.H. Talbot; G.M. Blake; D.S. Munro 2 cases of anaplastic thyroid cancer are described which developed after treatment of hyperthyroidism with iodine-131. 11 6 2009 © 1984 S. Karger AG, Basel 1984 Copyright / Drug Dosage / Disclaimer Copyright...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Thyroid cancer, differentiated Bone and pulmonary metastases Regional metastases Thyroid cancer Childhood Oncology...

...J. Nĕmec; J. Soumar; V. Zamrazil; D. Pohunková; K. Motlik; P. Miřejovský Differentiated thyroid cancers were found in mother and son. The diagnosis was made first in the boy where papillary and follicular cancer with lymph node involvement and lung metastatic dissemination was diagnosed at the age...

...J. Němec; J. Soumar; V. Zeman; V. Nahodil; V. Zamrazil; V. Šmejkal, jr. Differentiated (papillary) thyroid cancer was detected 17 years following radioiodide 131 I treatment for toxic multinodular goiter. 21 cases of thyroid cancers with previous 131 I therapy for hyperthyroidism were summarised...

... the development and initial validation of the MDASI-Thyroid Cancer module (MDASI-THY). Methods: A list of thyroid-cancer-specific symptoms was generated through focus groups and interviews with thyroid cancer patients, clinicians and researchers. These MDASI-THY items were added to the original MDASI...

...Kanako Yamanaka; Yasuhiro Ito; Noriko Okuyama; Katsuhisa Noda; Hitoshi Matsumoto; Hiroshi Yoshida; Akira Miyauchi; Mariana Capurro; Jorge Filmus; Eiji Miyoshi In 123 patients with thyroid cancer, expression of glypican 3 (GPC3) was immunohistochemically investigated in tissue samples...

.... Differential diagnosis Follicular tumor Gene expression profile Thyroid cancer A major concern in the diagnosis of thyroid tumors is accurate differentiation of benign and malignant tumors. Such differentiation is usually accomplished by a combination of physical examination, ultrasonography...

... in the expression pattern of ER-β variants have also been compared between normal and malignant thyroid tissues. In addition, the ER-α and ER-β expression in thyroid tissues was also compared between premenopausal and postmenopausal patients. ER-α ER-β Real-time RT-PCR Thyroid cancer 21 11...